Skip to main content
. 2021 Mar 11;14:711–719. doi: 10.2147/JPR.S290852

Figure 4.

Figure 4

The proportion of clinically significant PHN at 4, 8 and 12 weeks after treatment in both groups. Gray and black indicate the proportion of clinically significant PHN in group C and group P, respectively. *P < 0.05 compared to the pretreatment.